StockData
INSMED Inc logo

INSMED Inc (INSM) stock

INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3099% above fair value
$121.86−1.02 (-0.83%)

Close on Nov 17, 2026Market cap $26.73BP/E –Yield –

Insmed price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Insmed's price to sales ratio was 23.2× on Nov 11, 2026, against 98.8× a year earlier. Over the last 5 years it ranged from 9.3× to 100.5×, with a median of 21.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202623.2×−59.6
2025Dec 31, 202582.8×+46.8
2024Dec 31, 202436.0×+20.2
2023Dec 29, 202315.8×+5.7
2022Dec 30, 202210.0×−8.5
2021Dec 31, 202118.6×−1.5
2020Dec 31, 202020.1×−1.1
2019Dec 31, 201921.2×−26.2
2014Apr 30, 201447.4×−82.6
2013Jan 31, 2013130.0×−18.7
2012Dec 31, 2012148.7×+131.2
2011Dec 30, 201117.5×+17.5
2010Dec 31, 20100.0×–

More Insmed figures

See a number that looks wrong?